Tag: Terumo

radioembolization

Combining targeted Holmium-166 radioembolization with systemic therapy improves response rates in...

This article is sponsored by Terumo. The first prospective study on the combination of peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and Holmium-166 (166Ho) radioembolization...
BioPearl

New randomised study investigating distal radial access, DISCO RADIAL, launches

Terumo has announced the launch of a new randomised clinical trial: the DIStal vs. COnventional RADIAL access trial (DISCO RADIAL). The trial compares the...
QuiremSpheres

QuiremScout shows superior predictive value to technetium 99m macroaggregated albumin during...

A recent study comparing holmium-166 (QuiremSpheres, from Terumo) to technetium-99m-macroaggregated albumin (99mTc-MAA) as a work up for selective internal radiation therapy (SIRT) has found...

Orchestra BioMed announce FDA breakthrough device designation for Virtue sirolimus-eluting balloon

Orchestra BioMed, in partnership with Terumo Corporation, today announced that the company has secured breakthrough device designation by the US Food and Drug Administration...
Virtue sirolimus-eluting balloon

Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra...

Orchestra BioMed and Terumo have formed a global strategic partnership for the development and commercialisation of Virtue sirolimus-eluting balloon (SEB) in the percutaneous coronary...
SIRT

QuiremScout, the first and only product indicated for SIRT work-up, receives...

QuiremScout (Quirem Medical) has received CE mark, making it available for clinical centres throughout Europe. QuiremScout is designed to advance the SIRT (selective internal...

Terumo gets CE mark for Kanshas drug-coated balloon catheter for lower...

Terumo has announced receiving the CE mark for its Kanshas drug-coated balloon catheter used in the treatment of lower extremity peripheral arterial disease. With...

Vascutek and Bolton Medical merge to become Terumo Aortic

Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into a single, integrated business, Terumo Aortic.

Vascutek and Bolton Medical merge to become Terumo Aortic

Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into a single, integrated business, Terumo Aortic.

Terumo to acquire large bore vascular closure device to expand its...

Terumo Corporation has announced that it has entered into an agreement to acquire assets related to the large bore vascular closure device, Xpro System,...
QuiremSpheres

Terumo launches QuiremSpheres microspheres in Europe

Terumo has announced that it has launched QuiremSpheres microspheres in Europe on 18 September. QuiremSpheres, the next generation of selective internal radiation therapy (SIRT) microspheres...

CIRSE launches Europe-wide study of transarterial chemoembolization with Terumo Lifepearl

  The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has launched its CIRSE Registry for LifePearl Microspheres (CIREL), a new European-wide observational study that...
Interventional News for specialists

First patient enrolled in new study of abbreviated DAPT post-stent in...

Gillian Jessurun (Treant Zorggroep, Scheper Hospital Emmen, The Netherlands) has enrolled the first patient in the investigator-initiated MASTER DAPT (Management of patients post bioresorbable...

Terumo announces first commercial clinical case using Quiremspheres

Terumo Europe NV has announced the first commercial clinical case using Quiremspheres—the next generation radioembolization microspheres for advanced unresectable liver cancer. Quiremspheres are the only...

Gireesh Mukund Warawdekar

“Interventional radiology has always been characterised by its innovative spirit. We are now seeing progress with new procedures being developed to create percutaneous arteriovenous fistulae....

Terumo sets sight on Bolton to accelerate growth of vascular graft...

Terumo Corporation has announced that it has entered into a definitive agreement under which it has agreed to acquire Bolton Medical from its parent...

Terumo signs to acquire St Jude Medical and Abbott’s vascular closure...

Terumo has reached an agreement with Abbott and St Jude Medical to acquire certain products owned by both for a total of US$1.12 billion. Based...